
Origins of Cancer Immunotherapy, ft. Dr. Steven Rosenberg
The ImmunoVerse™
00:00
FDA approval of TIL for metastatic melanoma
Steven Rosenberg reflects on the long journey to TIL approval, mixed emotions about the delay, and its significance alongside CAR-T approvals.
Play episode from 11:45
Transcript


